介入性心臟病學設備市場規模、佔有率、成長分析、按產品、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年，介入性心臟病學設備的全球市場規模為131億美元，從2023年的140.6億美元成長到2031年的247億美元，預計在預測期內（2024-2031年）將成長。年增率為7.3%。

由於創新心血管設備的進步，介入性心臟病學設備市場正在顯著成長。循環系統性心臟科醫師是接受心血管疾病訓練的專家，他們主要使用導管（促進血管成形術和置入術等微創手術的軟性管）。這些手術為患有各種心臟病（通常與高血壓和糖尿病相關）的患者提供了開放性手術的可行替代方案。此外，這些設備還可以解決導致四肢動脈斑塊積聚的周邊血管問題。市場包括導管、球囊、支架、過濾器等。儘管輕鬆獲得監管批准對市場擴張做出了積極貢獻，但由於嚴格的政府法規和核准流程，挑戰仍然存在，這可能會阻礙該行業的整體成長潛力。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 案例研究
• 客戶和購買標準分析
• 貿易分析
• 原料分析

介入性心臟病學設備市場規模：依產品分類

• 市場概況
• 冠狀動脈支架
  • 裸金屬支架 (Bms)
  • 藥物釋放型支架 (Des)
  • 其他
• 結構性心臟裝置
  • 心臟瓣膜
  • 封堵器及其他
• 血管成形術用氣球
• 導管
  • 診斷導管
  • 血管造影術檢查
  • IVUS
  • 治療導管
  • 切除術
  • 血栓切除術
  • 消融
• 栓塞防護裝置

按最終用戶分類的介入性心臟病學設備市場規模

• 市場概況
• 醫院和 ASC
• 導尿實驗室及其他

按地區分類的介入性心臟病學設備市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Abbott Laboratories
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Medtronic PLC
• Terumo Corporation
• Biotronik SE & Co. KG
• Biosensors International Group Ltd
• ACIST Medical Systems
• Cardinal Health, Inc.
• Cook Medical Inc.
• Koninklijke Philips NV
• Edwards Lifesciences Corporation
• Nano Therapeutics Pvt. Ltd.
• AngioDynamics, Inc.
• Inari Medical, Inc.
• Genetesis, Inc.
• OptiMed Medical Instruments GmbH
• Meril Life Sciences Pvt. Ltd.
• OrbusNeich Medical

結論和建議

Global Interventional Cardiology Devices Market size was valued at USD 13.1 billion in 2022 and is poised to grow from USD 14.06 billion in 2023 to USD 24.7 billion by 2031, growing at a CAGR of 7.3% during the forecast period (2024-2031).

The market for interventional cardiology is seeing significant growth driven by advancements in innovative cardiovascular devices. Interventional cardiologists, trained specialists in cardiovascular diseases, primarily utilize catheters-flexible tubes that facilitate minimally invasive procedures like angioplasty and stenting. These techniques offer a viable alternative to open surgery for patients with various heart conditions, often associated with hypertension and diabetes. Additionally, these devices address peripheral vascular problems that lead to plaque build-up in limb arteries. Market offerings include catheters, balloons, stents, and filters. While the ease of obtaining regulatory licenses contributes positively to market expansion, challenges remain due to stringent government regulations and approval processes that may hinder overall growth potential in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Interventional Cardiology Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Interventional Cardiology Devices Market Segmental Analysis

Global Interventional Cardiology Devices Market is segmented by product, end user and region. Based on product, the market is segmented into coronary stents, structural heart devices, angioplasty balloons, catheters and embolic protection devices. Based on end user, the market is segmented into hospitals & ASCS and catheterization labs & others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Interventional Cardiology Devices Market

The global interventional cardiology devices market is primarily driven by the increasing prevalence of lifestyle habits such as high saturated fat intake, excessive salt consumption, alcohol use, and smoking, all of which contribute significantly to the risk of coronary artery disease (CAD). The rise in tobacco use and sedentary lifestyles further exacerbates this issue, leading to a growing incidence of obesity and CAD, thereby propelling the demand for interventional cardiology devices. As individuals become more aware of the health implications associated with these habits, there is a heightened need for advanced medical solutions, thus fostering growth in the interventional cardiology devices sector.

Restraints in the Global Interventional Cardiology Devices Market

The Global Interventional Cardiology Devices market faces significant restraints due to the evolving and complicated regulatory standards that govern medical device approvals. These regulations are influenced by various legal factors and are particularly challenging to navigate. Stringent scrutiny is required to ensure that medical devices meet high performance and quality benchmarks, which is essential for safeguarding public safety. Consequently, these rigorous and intricate certification processes may hinder the growth of the market, as manufacturers strive to comply with such demanding requirements while also trying to adapt to the changing needs of customers and the healthcare landscape.

Market Trends of the Global Interventional Cardiology Devices Market

The Global Interventional Cardiology Devices market is witnessing significant growth, driven primarily by the rising prevalence of obesity-related cardiovascular diseases and an increase in coronary artery disease due to unhealthy lifestyle choices. As sedentary lifestyles, smoking, and excessive alcohol consumption become more common, the demand for advanced interventional cardiology devices is surging. These devices offer cardiologists the ability to conduct life-saving procedures with improved safety and efficiency, minimizing complications. Consequently, the market is poised for expansion, fueled by technological advancements and an increasing focus on preventive and interventional cardiac care. As awareness grows, investment in innovative solutions will likely contribute to sustained market momentum.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Customer & Buying Criteria Analysis
• Trade Analysis
• Raw Material Analysis

Global Interventional Cardiology Devices Market Size by Product & CAGR (2024-2031)

• Market Overview
• Coronary Stents
  • Bare-Metal Stent (Bms)
  • Drug-Eluting Stent (Des)
  • Others
• Structural Heart Devices
  • Heart Valves
  • Occluders & Others
• Angioplasty Balloons
• Catheters
  • Diagnostic Catheters
  • Angiography
  • Ivus
  • Treatment Catheters
  • Atherectomy
  • Thrombectomy
  • Ablation
• Embolic Protection Devices

Global Interventional Cardiology Devices Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals & Ascs
• Catheterization Labs & Others

Global Interventional Cardiology Devices Market Size & CAGR (2024-2031)

• North America (Product, End User)
  • USA
  • Canada
• Europe (Product, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosensors International Group Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACIST Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nano Therapeutics Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inari Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genetesis, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptiMed Medical Instruments GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrbusNeich Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations